Chase C. Leavitt, General Counsel/Secretary at Oncternal Therapeutics, Inc. (ONCT), bought 25,000 shares at $0.29 ($7K) on 2023-04-12, disclosed to the SEC on 2023-04-14.
Open-market purchase of $7k ONCT by General Counsel/Secretary. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.29 | 15,000 | $4K | 60.0% |
| 2 | $0.29 | 10,000 | $3K | 40.0% |
| Total | $0.29 avg | 25,000 | $7K | 100% |
| Filing → |
| ONCT | BUY | 2022-01-31 | $23K | — | Filing → |
| ONCT | BUY | 2021-06-15 | $8K | — | Filing → |
| LCTX | BUY | 2019-08-15 | $5K | — | Filing → |